Management Team

Born 1967, MBA, Dipl. Ing., CPA

• CEO & CFO Curasight A/S (2016-)
• EVP Biofac Group (pharma; 2015-2016)
• Ass. Partner Capidea Capital Fund (Private equity; 2012-2014)
• Partner/EVP Mezzanin Capital A/S (Private equity; 2004-2012)
• EVP HNC Group A/S (2002-2004)
• Board member; Curasight A/S, Primodan A/S and other companies.
• Certified Public Accountant (CPA) and B.Sc in finance and accounting – Copenhagen Business School (CBS)
• MBA - University of Southern Denmark, Diploma in Engineering from DTU - Technical University of Denmark (DTU)

Ulrich Krasilnikoff on LinkedIn

Born 1963, MD, PhD, DMSc, MBA

• CSO and co-founder Curasight (2013-)
• Professor at the University of Copenhagen, Chief Physician at Rigshospitalet - the National University Hospital of Denmark (research focused on molecular imaging with PET and PET/MRI and theranostics in cancer)
• Head of Cluster for Molecular Imaging (CMI) (2004-)
• Holder of an ERC Advanced Grant, has published more than 500 peer-review articles, has received numerous prestigious scientific awards over the years.
• Member of the Danish Academy of Technica Sciences (ATV) (2015-)
• Founder FlouGuide (2018)
• Co-founder Minerva Imaging (2011).
• Founding Editor in Chief Diagnostics (2011-) and International Associate Editor Journal of Nuclear Medicine (2019-)
• MD, PhD, DMSc - University of Copenhagen, Master of Business Administration (MBA) - Copenhagen Business School (CBS)

Andreas Kjær on LinkedIn

Born 1963, MSc Pharm, MBA

• CDO, COO Curasight (2022-)
• CEO & Founder ROS Therapeutics (2018-)
• Board Chairman AimVion A/S (2020-)
• CDO & CEO Azanta (2009-2017
• MD REGUNIC (2009-)
• SVP Prod. Devpt. Santaris Pharma (2007-8)
• Affairs Mgr to EVP Genmab A/S (1999-2007)

MSc Pharma - School of Pharmaceutical Sciences at University of Copenhagen, MBA -Copenhagen Business School

Hanne Damgaard Jensen on Linkedin